Zacks Investment Management’s NEOPHOTONICS CORP NPTN Stock Holding History
Bought
Maintained
Sold
Other funds holding NPTN
PCMI
AIC
WA
MCM
Zacks Investment Management's NPTN Position: Q4 2020 in Review
Zacks Investment Management sold out of NEOPHOTONICS CORP (NPTN) in Q4 2020, closing a stake of 89,117 shares — an estimated $543K sold.
Zacks Investment Management first reported a position in NPTN in Q2 2020 and held it in 2 quarters. The position peaked at $822K in Q2 2020. 138 funds tracked by Wall St. Rank hold NPTN as of Q4 2020.
- Zacks Investment Management reported no remaining NEOPHOTONICS CORP position as of Q4 2020 after selling out during the quarter.
- Zacks Investment Management sold 89,117 NEOPHOTONICS CORP shares in Q4 2020, an estimated $543K.
- Zacks Investment Management first reported a position in NEOPHOTONICS CORP in Q2 2020 and held it in 2 quarters.
- Zacks Investment Management's NEOPHOTONICS CORP position peaked at $822K in Q2 2020.
- 138 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q4 2020.
Based on Zacks Investment Management's 13F filing for Q4 2020, filed 16 Feb 2021.